Bridging the gap between in silico and in vivo: modeling opioid disposition in a kidney proximal tubule microphysiological system
Authors:
Preprint
Abstract
Background: Opioid overdose, dependence, and addiction are a major public health crisis. Patients with chronic kidney disease (CKD) are at high risk of opioid overdose, therefore novel methods that provide accurate prediction of kidney clearance (CL r ) and systemic disposition of opioids in CKD patients can facilitate the optimization of therapeutic regimens. Methods: We conducted prediction of kidney clearance and systemic disposition of morphine and its active metabolite morphine-6-glucuronide (M6G) in CKD patients using a vascularized human proximal tubule microphysiological system (VPT-MPS) coupled with a parent-metabolite full body physiologically-based pharmacokinetic (PBPK) model. Results: The VPT-MPS, populated with a human umbilical vein endothelial cell (HUVEC) channel and an adjacent human primary proximal tubular epithelial cells (PTEC) channel, successfully demonstrated secretory transport of morphine and M6G from the HUVEC channel into the PTEC channel in a time-dependent manner; transporter inhibitors decreased translocation by 74.3% and 63.6%, respectively. The in vitro data generated by VPT-MPS were incorporated into a mechanistic kidney model and parent-metabolite full body PBPK model to predict CL r and systemic disposition of morphine and M6G. The model successfully predicted CL r within 1.5-fold, and the plasma concentration-time profiles of morphine and M6G in both healthy subjects and CKD patients, with absolute average fold error values <1.5. Conclusions: A microphysiological system together with mathematical modeling successfully predicted kidney clearance and systemic disposition of opioids in CKD patients and healthy subjects.Keywords
All Related Versions
- Published version: Scientific Reports, 11 (1), 1.
This publication has 47 references indexed in Scilit:
- Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessmentIntegrative Biology, 2013
- Morphine metabolism, transport and brain dispositionMetabolic Brain Disease, 2011
- Transepithelial fluxes of adenosine and 2′-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3American Journal of Physiology-Renal Physiology, 2009
- Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handlingToxicology and Applied Pharmacology, 2008
- Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney SlicesThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Lack of effect of ondansetron on the pharmacokinetics and analgesic effects of morphine and metabolites after single‐dose morphine administration in healthy volunteersBritish Journal of Clinical Pharmacology, 2001
- Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving MorphineClinical Pharmacokinetics, 1993
- Morphine Pharmacokinetics and Metabolism in HumansClinical Pharmacokinetics, 1993
- Drug Dosage in Renal DiseaseClinical Pharmacokinetics, 1976
- The distribution of p-aminohippuric acid in rat kidney slices. I. Tubular localizationKidney International, 1973